Posts

Showing posts from February, 2024

Clinical Validation of the cobas HPV Test on the cobas 6800 System for the Purpose of Cervical Screening | Journal of ... - American Society for Microbiology

[unable to retrieve full-text content] Clinical Validation of the cobas HPV Test on the cobas 6800 System for the Purpose of Cervical Screening | Journal of ...    American Society for Microbiology

HPV Vaccine | Human Papillomavirus (HPV) | CDC - CDC

Image
Children ages 11–12 years should get two doses of HPV vaccine, given 6 to 12 months apart . HPV vaccines can be given starting at age 9. Children who start the HPV vaccine series on or after their 15th birthday need three doses, given over 6 months. If your teen isn't vaccinated yet, talk to their doctor about doing so as soon as possible.

Stress and impetigo: Are they connected? - Medical News Today

Image
Stress does not cause impetigo but may weaken the immune system, putting a person at risk of developing this skin condition. The skin serves as a protective barrier from the external environment. Skin infections, such as impetigo, often happen when breaks or punctures in the skin receive exposure to bacteria. This article explores the question of whether stress can cause impetigo and other possible triggers of impetigo. Impetigo is a highly contagious skin infection affecting the superficial skin layer. It can occur due to one or both group A Streptococcus and Staphylococcus aureus bacteria. It spreads mainly through close contact with a person with the infection or through contact with their personal items. It commonly affects children between the ages of 2 and 5 years but can occur at any age. The global prevalence of impetigo is 11.2% in children in comparison to 4.9% in adults. There are two types of impetigo: Nonbullous impetigo: This is the most common type. It begins as clu...

Living Well With HPV: 5 Steps for Safer Sex - Everyday Health

Image
More than half of all men and women who are sexually active will be infected by the human papillomavirus (HPV) at some time in their lives. But "most women and men with the virus will never know they have it," says Vanessa Cullins, MD, MPH, a board-certified obstetrician-gynecologist and the former vice president for medical affairs at Planned Parenthood Federation of America. Most people infected with HPV do not develop any symptoms or health problems from the virus because the body's immune system is able to fight off the infection. "For the overwhelming majority of people, having an HPV infection has no impact on their lives," Dr. Cullins says. Still, some people do develop genital warts, which are caused by certain types of HPV, and some women learn they have HPV after an abnormal Pap smear, in which cells from the cervix are examined for cancerous or precancerous chang...

Modified host defence peptide GF19 slows TNT-mediated spread of corneal herpes simplex virus serotype I infection ... - Nature.com

Image
Abstract Corneal HSV-1 infections are a leading cause of infectious blindness globally by triggering tissue damage due to the intense inflammation. HSV-1 infections are treated mainly with antiviral drugs that clear the infections but are inefficient as prophylactics. The body produces innate cationic host defence peptides (cHDP), such as the cathelicidin LL37. Various epithelia, including the corneal epithelium, express LL37. cHDPs can cause disintegration of pathogen membranes, stimulate chemokine production, and attract immune cells. Here, we selected GF17, a peptide containing the LL37 fragment with bioactivity but with minimal cytotoxicity, and added two cell-penetrating amino acids to enhance its activity. The resulting GF19 was relatively cell-friendly, inducing only partial activation of antigen presenting immune cells in vitro. We showed that HSV-1 spreads by tunneling nanotubes in cultured human corneal epithelial cells. GF19 given before infection was able to block ...

Cutaneous Manifestations of HIV: Overview, Manifestations by HIV Disease Stage, Manifestations in HIV-Infected ... - Medscape Reference

Cedeno-Laurent F, Gómez-Flores M, Mendez N, Ancer-Rodríguez J, Bryant JL, Gaspari AA, et al. New insights into HIV-1-primary skin disorders. J Int AIDS Soc . 2011 Jan 24. 14:5. [QxMD MEDLINE Link]. [Full Text]. Altman K, Vanness E, Westergaard RP. Cutaneous manifestations of human immunodeficiency virus: a clinical update. Curr Infect Dis Rep . 2015 Mar. 17(3):464. [QxMD MEDLINE Link]. Kanwugu ON, Adadi P. HIV/SARS-CoV-2 coinfection: A global perspective. J Med Virol . 2021 Feb. 93 (2):726-732. [QxMD MEDLINE Link]. Almutairi N, Schwartz RA. COVID-19 with dermatologic manifestations and implications: An unfolding conundrum. Dermatol Ther . 2020 Sep. 33 (5):e13544. [QxMD MEDLINE Link]. Britto GR, Augustine M. Mucocutaneous manifestations of human immunodeficiency virus (HIV) infection in children in relation to the degree of immunosuppression. Int J Dermatol . 2019 Mar 29. [QxMD MEDLINE Link]. Ekpe O, Onunu AN, Forae GD, Okwara B. Clinico...

Free STI testing kits now available through Genesee County Health Department - Flint Beat

Image
Flint, MI — The Genesee County Health Department (GCHD) now offers free sexually transmitted infection (STI) self-testing kits. GCHD Public Health Nurse Supervisor Jessica Parks said that the department decided to get the kits in response to a growing number of STIs in the county. "[We wanted] to increase access to STI testing to address the rise in STIs, making access, you know, easy to meet individuals where they are, because we understand that … people sometimes have barriers to accessing care," she said. The kits allow individuals to test for gonorrhea, chlamydia, trichomoniasis, HIV and syphilis from home. Gonorrhea, chlamydia and trichomoniasis are all tested via a urine sample, Parks explained, and HIV and syphilis are tested through a blood sample. All of the supplies needed to collect the samples are provided in the kits, and once the samples are collected, individuals can use a pre-paid mailing package from the kit to send th...

A novel tailed primer nucleic acid test for detection of HPV 16, 18 and 45 DNA at the point of care | Scientific Reports - Nature.com

Image
Abstract Cervical cancer is a leading cause of death for women in low-resource settings despite being preventable through human papillomavirus (HPV) vaccination, early detection, and treatment of precancerous lesions. The World Health Organization recommends high-risk HPV (hrHPV) as the preferred cervical cancer screening strategy, which is difficult to implement in low-resource settings due to high costs, reliance on centralized laboratory infrastructure, and long sample-to-answer times. To help meet the need for rapid, low-cost, and decentralized cervical cancer screening, we developed tailed primer isothermal amplification and lateral flow detection assays for HPV16, HPV18, and HPV45 DNA. We translated these assays into a self-contained cartridge to achieve multiplexed detection of three hrHPV genotypes in a disposable cartridge. The developed test achieves clinically relevant limits of detection of 50–500 copies per reaction with extracted genomic DNA from HPV-positive cells. Final...